Form 13-F position report

HYPERFINE INC

Reported by Procyon Advisors LLC

HYPR CUSIP 44916K106 Manager CIK 0001804329

Reported 47,753 shares, unchanged from the prior quarter.

Reported value -37.3%; share count 0.0% vs. the prior quarter.

Unchanged
% of reported 13F value 0.02% This manager · Q2 2022
Shares 47,753 Quarter-end amount reported
Reported value $106,000 Fair value at quarter end
Consecutive quarters held 2 Through Q2 2022

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2022-03-31 169000
2022-06-30 106000
2022-09-30 39000
2022-12-31 40113
2023-03-31 68764
2023-06-30 102669
2023-09-30 97894
2023-12-31 53483
2024-03-31 47753
2024-06-30 40590
2024-09-30 51573
2024-12-31 42023
2025-03-31 34205
2025-06-30 34363
2025-09-30 69242
2025-12-31 46765
2026-03-31 51573
2026-06-30 64467
2026-09-30 38584

Quarterly position history

How this manager's reported quarter-end position changed over time.

19 quarters
Quarterly reported position history for HYPERFINE INC held by Procyon Advisors LLC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q3 2026 Unchanged 47,753 0 (0.0%) < 0.01% $38,584 2026-10-21
Q2 2026 Unchanged 47,753 0 (0.0%) < 0.01% $64,467 2026-07-09
Q1 2026 Unchanged 47,753 0 (0.0%) < 0.01% $51,573 2026-05-04
Q4 2025 Unchanged 47,753 0 (0.0%) < 0.01% $46,765 2026-01-07
Q3 2025 Unchanged 47,753 0 (0.0%) < 0.01% $69,242 2025-10-28
Q2 2025 Unchanged 47,753 0 (0.0%) < 0.01% $34,363 2025-07-09
Q1 2025 Unchanged 47,753 0 (0.0%) < 0.01% $34,205 2025-04-11
Q4 2024 Unchanged 47,753 0 (0.0%) < 0.01% $42,023 2025-01-15
Q3 2024 Unchanged 47,753 0 (0.0%) < 0.01% $51,573 2024-10-11
Q2 2024 Unchanged 47,753 0 (0.0%) < 0.01% $40,590 2024-08-02
Q1 2024 Unchanged 47,753 0 (0.0%) < 0.01% $47,753 2024-04-15
Q4 2023 Unchanged 47,753 0 (0.0%) < 0.01% $53,483 2024-01-18
Q3 2023 Unchanged 47,753 0 (0.0%) 0.01% $97,894 2023-10-10
Q2 2023 Unchanged 47,753 0 (0.0%) 0.01% $102,669 2023-07-17
Q1 2023 Unchanged 47,753 0 (0.0%) 0.01% $68,764 2023-04-10
Q4 2022 Unchanged 47,753 0 (0.0%) < 0.01% $40,113 2023-01-19
Q3 2022 Unchanged 47,753 0 (0.0%) < 0.01% $39,000 2022-10-17
Q2 2022 Unchanged 47,753 0 (0.0%) 0.02% $106,000 2022-07-11
Q1 2022 New 47,753 +47,753 (0.0%) 0.03% $169,000 2022-04-18

Who else reported the position

46 managers reported HYPERFINE INC for Q2 2022.

Managers reporting HYPERFINE INC in Q2 2022.
Manager Activity Shares Change % of reported 13F Reported value Tenure
HealthCor Management L P Added 2,749,400 +999,400 0.62% $6,131,000 3 qtrs
Monashee Investment Management LLC Reduced 1,742,490 -12,548 1.41% $3,886,000 3 qtrs
Fosun International Ltd Unchanged 1,742,020 0 0.54% $3,885,000 3 qtrs
Avidity Partners Management LP Unchanged 1,503,754 0 0.08% $3,353,000 3 qtrs
ARK Investment Management LLC Unchanged 1,000,000 0 0.02% $2,890,000 3 qtrs
PERCEPTIVE ADVISORS LLC Reduced 1,134,388 -365,612 0.08% $2,530,000 3 qtrs
Alphabet Inc Unchanged 898,720 0 0.11% $2,004,000 3 qtrs
Bain Capital Public Equity Management II LLC Reduced 864,945 -59,181 0.09% $1,929,000 3 qtrs
Opaleye Management Inc Unchanged 763,075 0 0.77% $1,702,000 3 qtrs
Alyeska Investment Group L P Unchanged 750,000 0 0.02% $1,673,000 3 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
June 30, 2022
Filed
July 11, 2022
Filing type
13F-HR
Position type
Stock

Voting authority reported

Sole
0
Shared
0
None
47,753

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.